PharmaShots | Incisive News in 3 Shots

Subscribe Now

ESC Congress 2018

Pfizer Announces Tafamidis P-III Transthyretin Cardiomyopathy (ATTR-ACT) study results

Pfizer Announces Tafamidis P-III Transthyretin Cardiomyopathy (ATTR-ACT) study results

August 28, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us